DENTIS CO. LTD
KKRX:2612002,410.00
KRW
-35.00
(-1.43%)
ISIN
KR7261200000
Return %
Stock
S&P 500
1Y
-52.18
14.20
3Y
-70.75
81.12
5Y
-76.83
68.34
Capital Structure
KRW
•
in mil. unless spec.Working Capital
KRW
•
in mil. unless spec.Growth Rates
KRW
•
in mil. unless spec.Quarterly Revenue
KRW
•
in mil. unless spec.Quarterly Earnings Per Share
KRW
•
in mil. unless spec.Quarterly Dividends Per Share
KRW
•
in mil. unless spec.Company Description
- CEO
- Ki-Bong Sim
- Full Time Employees
- 371
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Daegu South Korea
- IPO Date
- Jun 26, 2017
- Website
- dentis.co.kr
- Similar Companies
- Business
- Dentis Co., Ltd. is a South Korea-based medical device manufacturer primarily engaged in the research, development, production, and distribution of dental implants, operating room equipment, digital dentistry systems, and orthodontic solutions. Founded in 2005 and headquartered in Daegu, South Korea, the company operates across specialized medical and dental segments, serving dental clinics, general hospitals, oral surgery practices, and dental laboratories worldwide. The company's core product portfolio encompasses dental implant systems, including bone-level and tissue-level fixture lines marketed under the SQ, Cleanlant, OneQ, and AXEL brands; surgical instrument kits, prosthetics, and the SQUVA ultraviolet implant surface activator; digital dentistry equipment and additive manufacturing solutions under the ZENITH brand, including stereolithography, digital light processing, and liquid crystal display 3D printers, specialized printing resins, intraoral scanners, and computer-guided surgical software; medical and dental equipment under the LUVIS brand, comprising LED surgical operating lights, examination lights, dental unit chairs, and operating tables; regenerative biomaterials under the Ovis brand, including allograft, xenograft, and synthetic bone graft materials, as well as resorbable and non-resorbable barrier membranes; and digital clear aligner orthodontic solutions marketed under the SERAFIN brand alongside proprietary treatment planning software. In addition to manufactured hardware and consumables, the company provides clinical education and digital workflow support through educational platforms such as the Global Dental Implant Academy and the Dental Oral Digital Institute. Dentis distributes its products to more than 60 countries across North America, Europe, Asia-Pacific, Latin America, and the Middle East, supported by global subsidiaries including Dentis USA, Dentis Europe, and Dentis India. In recent corporate developments, Dentis expanded its international regulatory portfolio by securing U.S. Food and Drug Administration 510(k) clearance for ChecQ, a resonance frequency analysis device designed to assess dental implant stability and osseointegration, while obtaining expanded international certifications for its SQ implant system and LUVIS surgical chair solutions in key overseas markets such as China and the United States. To support sustained global sales growth, the company completed capital investments into new manufacturing infrastructure, including the construction of an additional implant production facility and the implementation of automated production processes for dental unit chairs and SERAFIN clear aligners. Furthermore, Dentis accelerated its direct market presence in Southeast Asia by establishing dedicated local operating subsidiaries in Vietnam and Thailand.